Health● Low40m ago · Nov 17, 2026, 1:03 PM
EU approves new drug against pancreatic cancer
GlobeAlert Desk · curated from Anadolu Ajansı [tr] · Türkiye · Western Europe
The European Union (EU) Commission has granted marketing authorization for a drug called Daraxonrasib, to be used in the treatment of pancreatic cancer that has spread to various parts of the body.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
More from Türkiye
World4h agoExploring Türkiye’s artisanal heritage through its citiesEuroNews [en]Business16h agoThe biggest story from Türkiye – which you probably missed!Daily Sabah · TürkiyePolitics1d agoTürkiye re-elected to the International Telecommunication Union council membershipAnadolu Ajansı [tr] · TürkiyeBusiness3d agoTürkiye Sigorta returned fund gains to TMSFNTV · Türkiye
More in Health
Health11m agoDo you suffer from high cholesterol? Here's what you need to know before eating cheeseAsharq Al-Awsat [ar] · Saudi ArabiaHealth12m agoHigh tobacco use among European women and girls is ‘worrying,’ WHO warnsEuroNews [en]Health41m agoCCMB study points to new way of tackling fungal infectionsThe HinduHealth1h agoRoche’s breast cancer pill Wilserdly approved in the U.S.Seeking Alpha Tech